Daniel M. Jones

机构：Dalhousie University, University of Ottawa, Ottawa Hospital, McGill University Health Centre, Horizon Health Network, The Ohio State University Wexner Medical Center, University of Saskatchewan, Oxford BioMedica (United Kingdom), Ottawa University

发表论文 106 篇 · 总被引 4632 次 · h-index 31

代表论文

• Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2 (2022 · Cell Host & Microbe · 被引 281)
• Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants (2023 · Cell Reports · 被引 191)
• Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants (2024 · Cell Reports · 被引 78)
• Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 49)
• Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector (2025 · Molecular Therapy · 被引 33)
• Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 31)